Eli Lilly drug slows Alzheimer's disease, study finds
Eli Lilly Co. s shares climbed in premarket trading after its experimental drug for Alzheimer s slowed the progress of the disease in a final stage...
Source: thepeninsulaqatar.com
Stay updated with breaking news from Andrew Baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eli Lilly Co. s shares climbed in premarket trading after its experimental drug for Alzheimer s slowed the progress of the disease in a final stage...
The company has said it expects 2023 to be a low point for COVID product sales, before potentially returning to growth in 2024.
UBS tells investors to stick to dependable defensives, given recent softness in economic numbers.
Nick Stone: This is the usual Safe Harbor statement. We will comment on our performance using constant exchange rates, or CER, unless stated otherwise.
AZN earnings call for the period ending March 31, 2023.